Advertisement

A new device to improve target localization for transcranial magnetic stimulation therapy

Published:August 02, 2019DOI:https://doi.org/10.1016/j.brs.2019.07.028

      Highlights

      • Standard methods for identifying the cranial midline introduce significant error.
      • A new device for identifying the cranial midline improves upon these inaccuracies.
      • The device can assist with localizing Beam F3 method TMS prefrontal cortex targets.

      Abstract

      Background

      Accurate identification of cranial midline structures is essential for many targeting techniques that use repetitive transcranial magnetic stimulation (rTMS), including the Beam F3 method used for depression treatment.

      Objective

      Evaluate whether a novel, laser-sighted device will assist with more accurate identification of the cranial midline relative to standard scalp-based measurement procedures.

      Methods

      Three trained TMS technicians performed repeated scalp-based measurements to identify the inion and vertex on five subjects (n = 54 measurements). Measurements were compared to points identified with the midline localizer device and the true midline as defined by MRI midline structures.

      Results

      Use of the midline localizer was more accurate for midline identification than technician measurement (p = 0.00025) and the ratio of localizing the midline within 5 mm was higher (78% versus 54%, p = 0.008).

      Conclusion

      Use of a laser-sighted midline localizer device can improve the accuracy of scalp measurements associated with target localization for rTMS treatment protocols.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Perera T.
        • et al.
        The clinical TMS society consensus Review and treatment recommendations for TMS therapy for major depressive disorder.
        Brain Stimul. 2016; 9: 336-346
        • Fox M.D.
        • Liu H.
        • Pascual-Leone A.
        Identification of reproducible individualized targets for treatment of depression with TMS based on intrinsic connectivity.
        Neuroimage. 2013; 66: 151-160
        • Mir-Moghtadaei A.
        • et al.
        Concordance between BeamF3 and MRI-neuronavigated target sites for repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex.
        Brain Stimul. 2015; 8: 965-973
        • Johnson K.A.
        • et al.
        Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial.
        Brain Stimul. 2013; 6: 108-117
        • Beam W.
        • et al.
        An efficient and accurate new method for locating the F3 position for prefrontal TMS applications.
        Brain Stimul. 2009; 2: 50-54
        • Deng Z.D.
        • Lisanby S.H.
        • Peterchev A.V.
        Electric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs.
        Brain Stimul. 2013; 6: 1-13
        • Levkovitz Y.
        • et al.
        Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial.
        World Psychiatry. 2015; 14: 64-73